Rock Edwin Insider Trades

Insider Trading History

Track insider trading activity for Rock Edwin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
GlycoMimetics
GlycoMimetics GLYC
Chief Medical Officer
Holding Value $10.7M 680,403 shares
Last Trade
Jun 21, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.96M 115,000 shares
$25.73
$15.70
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Medical Officer
Holding Value $11.9M 680,403 shares
Last Trade
Jun 21, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58.8k 115,000 shares
$0.51
$17.50
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Medical Officer
Holding Value $9.89M 565,403 shares
Last Trade
Jun 20, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$97.1k 190,000 shares
$0.51
$17.50
GlycoMimetics
GlycoMimetics GLYC
Chief Medical Officer
Holding Value $8.88M 565,403 shares
Last Trade
Jun 20, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.75M 190,000 shares
$25.00
$15.70
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Medical Officer
Holding Value $4.38M 250,000 shares
Last Trade
Jan 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 250,000 shares
$0.51
$17.50
GlycoMimetics
GlycoMimetics GLYC
Chief Medical Officer
Holding Value $3.93M 250,000 shares
Last Trade
Jan 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.8M 250,000 shares
$311.00
$15.70
GlycoMimetics
GlycoMimetics GLYC
Chief Medical Officer
Holding Value $5.9M 375,403 shares
Last Trade
Sep 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.29M 30,403 shares
$141.00
$15.70
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Medical Officer
Holding Value $6.57M 375,403 shares
Last Trade
Sep 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.9k 30,403 shares
$0.49
$17.50
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Medical Officer
Holding Value $6.04M 345,000 shares
Last Trade
Sep 21, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.3k 35,000 shares
$0.49
$17.50
GlycoMimetics
GlycoMimetics GLYC
Chief Medical Officer
Holding Value $5.42M 345,000 shares
Last Trade
Sep 21, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.83M 35,000 shares
$138.00
$15.70
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Medical Officer
Holding Value $4.28M 244,800 shares
Last Trade
Jan 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.2k 244,800 shares
$0.25
$17.50
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Medical Officer
Holding Value $5.43M 310,000 shares
Last Trade
Dec 22, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$53.7k 110,000 shares
$0.49
$17.50
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Medical Officer
Holding Value $3.5M 200,000 shares
Last Trade
Nov 15, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$55.5k 100,000 shares
$0.55
$17.50
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Medical Officer
Holding Value $1.75M 100,000 shares
Last Trade
Nov 14, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$55k 100,000 shares
$0.55
$17.50
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Medical Officer
Holding Value $3.5M 200,000 shares
Last Trade
Sep 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103k 200,000 shares
$0.51
$17.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up